[Secondary glaucoma in uveitis].
Secondary glaucoma represents a frequent complication especially in chronic forms of uveitis. Different immunological and mechanical alterations can be responsible for the elevation of intraocular pressure (IOP). To enable a tailored treatment strategy the diagnostic process has to include the search for characteristic findings which can be indicative for the underlying uveitis entity. Sometimes it can be difficult to distinguish inflammatory glaucoma from primary non-inflammatory forms of glaucoma as well as from steroid-induced elevation of IOP. Treatment of secondary glaucoma due to uveitis has to include not only medicinal and surgical lowering of IOP but also control of the inflammation, e.g. by immunosuppressive or antiviral drugs. Under normal conditions, beta-receptor antagonists and carbonic anhydrase inhibitors will represent first-line topical treatment. Besides cyclodestructive and filtrating procedures, the use of drainage implants has gained importance in the surgical treatment of secondary glaucoma due to intraocular inflammation.
Deuter
C M E
CM
Department für Augenheilkunde, Universitätsklinikum Tübingen. christoph.deuter@med.uni-tuebingen.de
Klinik
T
T
Müller
M
M
Geerling
G
G
Zierhut
M
M
D005901:Glaucoma / Q000175:diagnosis* / Q000209:etiology* / Q000601:surgery; D006801:Humans; D014605:Uveitis / Q000150:complications* / Q000175:diagnosis* / Q000628:therapy
Am J Ophthalmol. 2005 Sep;140(3):509-16
16196117
Klin Monbl Augenheilkd. 2007 Aug;224(8):641-6
17717780
Am J Ophthalmol. 2000 Sep;130(3):287-91
11020406
Arch Ophthalmol. 1978 Sep;96(9):1668-76
687212
Br J Ophthalmol. 2006 Jun;90(6):737-40
16714265
J Glaucoma. 2004 Dec;13(6):441-4
15534466
Br J Ophthalmol. 1990 Apr;74(4):223-7
2337547
Am J Ophthalmol. 1995 Jun;119(6):796-8
7785697
Br J Ophthalmol. 1991 Sep;75(9):519-23
1680389
Am J Ophthalmol. 2007 Jul;144(1):62-69
17493574
Am J Ophthalmol. 2008 May;145(5):834-40
18255045
Arch Ophthal. 1948 Apr;39(4):517-35
18123283
Am J Ophthalmol. 1987 Oct 15;104(4):430-1
3661656
N Engl J Med. 1998 Jul 30;339(5):300-6
9696640
Graefes Arch Clin Exp Ophthalmol. 2010 Apr;248(4):565-71
19937050
Invest Ophthalmol Vis Sci. 2001 Oct;42(11):2584-8
11581203
Trans Am Ophthalmol Soc. 1990;88:797-850
1965620
Am J Ophthalmol. 2004 Jul;138(1):46-54
15234281
Acta Ophthalmol Scand. 2000 Oct;78(5):576-9
11037918
J Glaucoma. 2004 Apr;13(2):96-9
15097253
Lab Invest. 1989 Mar;60(3):317-9
2648064
Br J Ophthalmol. 2000 Sep;84(9):999-1003
10966953
J Glaucoma. 2004 Dec;13(6):461-5
15534470
Ophthalmologica. 1999;213(5):300-4
10516518
Ophthalmologe. 2005 Jul;102(7):733-42; quiz 743-4
15947963
Am J Ophthalmol. 1996 Aug;122(2):171-82
8694085
Acta Ophthalmol Scand. 2000 Feb;78(1):71-6
10726794
Br J Ophthalmol. 2006 Jul;90(7):852-5
16597667
Br J Ophthalmol. 2003 Jul;87(7):879-84
12812891
Am J Ophthalmol. 1978 Jul;86(1):101-5
677220
J Glaucoma. 2002 Jun;11(3):189-96
12140394
Arch Ophthalmol. 1961 Jan;65:20-3
13734311
Int Ophthalmol. 2009 Oct;29(5):367-72
18563298
Can J Ophthalmol. 2008 Aug;43(4):462-7
18711462
Ophthalmology. 2007 Jul;114(7):1358-62
17296229
J AAPOS. 2005 Aug;9(4):336-40
16102483
Am J Ophthalmol. 1998 Jul;126(1):37-41
9683147
Klin Monbl Augenheilkd. 2004 May;221(5):339-42
15162275
Ophthalmology. 2000 Oct;107(10):1822-8
11013180